Corton Capital Inc. Viatris Inc Transaction History

Corton Capital Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $229,761 - $275,836	-20,387 Reduced 35.78%	36,594 $436,000
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $89,304 - $110,485	10,183 Added 21.76%	56,981 $617,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $99,764 - $118,074	10,403 Added 28.58%	46,798 $461,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $106,796 - $121,833	11,840 Added 48.22%	36,395 $363,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $28,409 - $37,858	3,088 Added 14.38%	24,555 $236,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $39,989 - $53,014	-4,586 Reduced 17.6%	21,467 $238,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $220,929 - $289,969	26,053 New	26,053 $222,000
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $432,606 - $533,475	-43,478 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $60,527 - $95,018	-6,170 Reduced 12.43%	43,478 $473,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $600,244 - $728,832	49,648 New	49,648 $672,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.